By activating both GIP and GLP-1 receptors, tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying
Data doesnt show strong evidence for the connection, but its something researchers will continue to study
February 2024 - On February 2, 2024, a federal judicial panel ordered the consolidation of at least 55 lawsuits into multidistrict litigation (MDL 3094) in the Eastern District of Pennsylvania
Anchor to BPC-157 Most protocols dose BPC-157 daily and calculate the TB-500 volume against that same draw, rather than dosing each peptide on a separate schedule
Inflammation Modulation: It doesnt just reduce inflammation
Clinical practice guidelines for GLP-1 receptor agonist monitoring